中国癌症杂志 ›› 2019, Vol. 29 ›› Issue (1): 1-8.doi: 10.19401/j.cnki.1007-3639.2019.01.001

• 专家述评与论著 • 上一篇    下一篇

2018年胰腺癌研究及诊疗新进展

杨 超,罗国培,刘 辰,虞先濬   

  1. 复旦大学附属肿瘤医院胰腺外科,复旦大学胰腺肿瘤研究所,上海市胰腺肿瘤研究所,复旦大学上海医学院肿瘤学系,上海 200032
  • 出版日期:2019-01-30 发布日期:2019-02-01
  • 通信作者: 虞先濬 E-mail: yuxianjun@fudanpci.org

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2018

YANG Chao, LUO Guopei, LIU Chen, YU Xianjun   

  1. Department of Pancreatic Surgery and Pancreatic Cancer Institute, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai Pancreatic Cancer Institute; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2019-01-30 Online:2019-02-01
  • Contact: YU Xianjun E-mail: yuxianjun@fudanpci.org

摘要: 胰腺癌是一种发病隐匿、进展快、疗效不佳、中位生存期短、预后极差的一种恶性肿瘤,素有“癌中之王”的称号。随着居民生活水平的提高和临床检出率的提升,近年来胰腺癌的发病率呈现逐年增长的趋势,成为威胁居民健康水平的重要因素。随着基础研究和临床研究的深入,胰腺癌的分子机制和临床分型特点越来越清晰,为攻克“癌王”提供了理论上的依据。本文对2018年胰腺癌的重大研究进展进行综述。

关键词: 胰腺癌, 流行病学, 基础研究, 临床研究, 进展

Abstract: Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence. Most patients remain asymptomatic, and the disease progresses rapidly. Due to economic development and improvement of clinical detection rate, incidence of pancreatic cancer is roaring, which becomes a serious health problem. Thanks to the development of basic and clinical research, more detailed information is obtained on pancreatic cancer, providing theoretical support for conquering “the king of cancer”. This review summarized recent high quality studies on pancreatic cancer.

Key words: Pancreatic cancer, Epidemiology, Basic research, Clinical research, Progress